Researchers detected Usutu virus RNA in nine of 818 wild carnivores sampled across the Netherlands, while no animals tested ...

DelveInsight's Pharmacogenomic Testing Service Market Insights report provides the current and forecast market analysis, individual leading pharmacogenomic testing service companies' market shares, ...

Opportunities include next-generation mRNA, viral vector and DNA platforms; needle-free, oral and nasal delivery; expanded ...

A six-year-old boy from Sussex has become one of only about 75 people worldwide to be diagnosed with an ultra-rare genetic ...

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

The U.S. Single-Cell Sequencing Market is projected to grow from USD 1.05 Billion in 2025 to USD 4.07 Billion by 2035, while ...

This article explores how biobanks, proteomics, and AI are enabling population-scale insights, earlier disease detection, and ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...